Dana Walters

Dana Walters, PhD, is a medical affairs professional specializing in rare diseases at BridgeBio. With a BS in Biochemistry from Gonzaga University and a PhD in Pharmaceutical Sciences from Washington State University, Dana has extensive experience in field medical roles, including positions at Pfizer and Seattle Genetics. They are committed to educating healthcare providers about the challenges faced by patients with rare diseases and have contributed to research on various therapeutic areas, including transthyretin amyloid cardiomyopathy and succinic semialdehyde dehydrogenase deficiency. Dana is currently serving as Director, Executive Medical Science Liaison at BridgeBio.